Schedule 13D ownership disclosure

Iterum Therapeutics plc

Security class unavailable · CUSIP: 00BF3W0Q3

Event date: 2018-05-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,726,514
Percent of class
12.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-033630
Form type
SC 13D
Filer
Iterum Therapeutics plc
CIK
CIK 1659323
Filed
Jun 11, 2018
Reporting period
May 30, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub